We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
KORU Medical Systems Inc | NASDAQ:KRMD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.84% | 2.40 | 2.27 | 2.77 | 2.44 | 2.27 | 2.40 | 52,313 | 05:00:14 |
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) today announced that management is scheduled to present at the following investor conferences in November:
10th Annual Craig-Hallum Alpha Select Conference (New York) Tuesday, November 12, 2019 One-on-One Meetings
Canaccord Genuity 2019 MedTech & Diagnostics Forum (New York) Thursday, November 21, 2019 Formal Presentation: 11:00 am ET One-on-One Meetings
A copy of the slides for each event may be accessed under “Company Info” in the “Investors” section of the Company’s website: www.korumedical.com.
About KORU Medical Systems
KORU Medical Systems develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
Forward-Looking Statements
The statements contained herein include prospects, statements of future expectations and other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's current views and assumptions and involve known and unknown risks and uncertainties, identified by words such as “scheduled”. Actual results, performance or events may differ materially from those expressed or implied in such forward-looking statements. Factors that may cause actual results to differ materially from current expectations and other risks are discussed in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K, which filings are available from the SEC and the Company’s website. The Company undertakes no obligation to update any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191107005932/en/
The Equity Group Inc. Devin Sullivan Senior Vice President 212-836-9608 dsullivan@equityny.com
Kalle Ahl, CFA Vice President 212-836-9614 kahl@equityny.com
1 Year KORU Medical Systems Chart |
1 Month KORU Medical Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions